State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 141 actively recruiting studies with Kansas sites out of 141 registered in total. The busiest research areas in Kansas are Breast Cancer, Cystic Fibrosis, Prostate Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Kansas Medical Center, AstraZeneca. By stage, Kansas trials break down as Phase 1 (22), Phase 2 (34), Phase 3 (46), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 141 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 141. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Cystic Fibrosis, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
NCT07398417 Phase 3
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal ...
Condition
Fibromyalgia
Enrollment
620 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT07029581 Phase 2
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Condition
Lewy Body Dementia Psychosis
Enrollment
180 pts
Location
United States, Bulgaria, Czechia
Sponsor
ACADIA Pharmaceuticals Inc.
NCT05839730 N/A
Recruiting
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
105 pts
Location
United States
Sponsor
Medtronic Cardiac Rhythm and H
NCT05370430 Phase 1
Recruiting
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Condition
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Enrollment
36 pts
Location
United States
Sponsor
PeproMene Bio, Inc.
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
NCT06990867 Phase 2, Phase 3
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Condition
Acute Ischemic Stroke
Enrollment
740 pts
Location
United States, Belgium, Bulgaria
Sponsor
Corxel Pharmaceuticals
NCT04389632 Phase 1
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Condition
Carcinoma, Non-Small Cell Lung
Enrollment
1,006 pts
Location
United States, France, South Korea
Sponsor
Seagen, a wholly owned subsidi
NCT04671667 Phase 2
Recruiting
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itse...
Condition
Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment
188 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06544265 Phase 1
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
Condition
B Cell Lymphoma
Enrollment
36 pts
Location
United States
Sponsor
Verismo Therapeutics
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT07565090 Phase 1
Recruiting
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP,...
Condition
Sudan Virus Disease
Enrollment
112 pts
Location
United States
Sponsor
International AIDS Vaccine Ini
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT06455449 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Su...
Condition
Polymyositis, Dermatomyositis
Enrollment
240 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06274047 Phase 3
Recruiting
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and...
Condition
Androgen Axis Suppression
Enrollment
120 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06289413 N/A
Recruiting
Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study
Condition
Autonomic Dysfunction
Enrollment
400 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT07169318 Phase 1
Recruiting
First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Condition
Influenza
Enrollment
78 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05332925 N/A
Recruiting
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Condition
Lung Cancer
Enrollment
25 pts
Location
United States
Sponsor
Jun Zhang, MD, PhD
NCT06273748 N/A
Recruiting
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
Condition
Uveitis
Enrollment
290 pts
Location
United States, Belgium, Greece
Sponsor
Meyer Children's Hospital IRCC
NCT04624490 Phase 1
Recruiting
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subje...
Condition
Asthma
Enrollment
260 pts
Location
United States
Sponsor
Mario Castro, MD, MPH
NCT07259746 N/A
Recruiting
Study of Student Flourishing
Condition
Healthy
Enrollment
2,500 pts
Location
United States, Canada, New Zealand
Sponsor
Flourish Science, Inc.
NCT06279013 N/A
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and P...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
Page 1 of 6 — 141 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology